A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
11/10/2021 - 10 minutes
Cellectis
European Cancer Deals Increasingly Focus on Natural Killer Cells
Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene,…
23/02/2021 - 6 minutes
Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference
Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American…
17/12/2020 - 6 minutes
Get to Know 15 Awesome Biotechs in Paris
Paris attracts millions of tourists to see some of the world’s most iconic monuments: the…
18/02/2020 - 12 minutes
Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential
An off-the-shelf, gene edited CAR T-cell therapy, developed by the French biotech Cellectis, could be…
14/11/2019 - 2 minutes
The Billion-Euro European Biotech Companies in 2018
Here’s the list of the European biotech companies, both public and private, that are worth…
29/10/2018 - 7 minutes
French Biotech Develops a New Generation of Safer CAR-T Cells
Cellectis is developing a new type of chimeric antigen receptor that could improve the production…
13/06/2018 - 2 minutes
French CAR-T Developer Raises $164M Despite a Challenging Road
Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in…
11/04/2018 - 3 minutes
The Most Important Battle in Gene Editing: CRISPR versus TALEN
Despite all the hype, CRISPR is still not in the clinic as a standalone therapy…
13/03/2018 - 6 minutes
French Biotech Gets a CRISPR Patent for CAR-T Research
Update (16/02/2018): On top of the European patent it got last July, Cellectis now also…
16/02/2018 - 2 minutes
Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad
Most CAR-T stocks rose on the news that Big Biotech Celgene has plans to acquire…
23/01/2018 - 2 minutes
An Update on What’s New in the French Biotech Industry
Here's a closer look at the French biotech ecosystem in 2017, which remains one the…
17/01/2018 - 4 minutes
